In this study, we aim to deliver CDK4/6i PAL and autophagy inhibitor hydroxychloroquine sulfate (HCQ) considering both the aspects of cancer biology and chemical structure of active pharmaceutical ingredient (API). Here, CDK4 is linked to cancer.